Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50


Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.

Edelmann MJ, Nicholson B, Kessler BM.

Expert Rev Mol Med. 2011 Nov 17;13:e35. doi: 10.1017/S1462399411002031. Review.


Replication of the rotavirus genome requires an active ubiquitin-proteasome system.

López T, Silva-Ayala D, López S, Arias CF.

J Virol. 2011 Nov;85(22):11964-71. doi: 10.1128/JVI.05286-11. Epub 2011 Sep 7.


Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease.

Karpe YA, Lole KS.

J Gen Virol. 2011 Sep;92(Pt 9):2088-92. doi: 10.1099/vir.0.033738-0. Epub 2011 Jun 8.


Three amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation.

Córdoba L, Huang YW, Opriessnig T, Harral KK, Beach NM, Finkielstein CV, Emerson SU, Meng XJ.

J Virol. 2011 Jun;85(11):5338-49. doi: 10.1128/JVI.02278-10. Epub 2011 Mar 30.


A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).

Kouroukis CT, Fernandez LA, Crump M, Gascoyne RD, Chua NS, Buckstein R, Turner R, Assouline S, Klasa RJ, Walsh W, Powers J, Eisenhauer E.

Leuk Lymphoma. 2011 Mar;52(3):394-9. doi: 10.3109/10428194.2010.546015. Erratum in: Leuk Lymphoma. 2011 Jun;52(6):1160. Gascoyne, Randy D [added].


From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety.

Meng XJ.

Virus Res. 2011 Oct;161(1):23-30. doi: 10.1016/j.virusres.2011.01.016. Epub 2011 Feb 21. Review.


Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

Chen D, Frezza M, Schmitt S, Kanwar J, Dou QP.

Curr Cancer Drug Targets. 2011 Mar;11(3):239-53. Review.


The nucleotides on the stem-loop RNA structure in the junction region of the hepatitis E virus genome are critical for virus replication.

Cao D, Huang YW, Meng XJ.

J Virol. 2010 Dec;84(24):13040-4. doi: 10.1128/JVI.01475-10. Epub 2010 Oct 13.


Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step.

Widjaja I, de Vries E, Tscherne DM, García-Sastre A, Rottier PJ, de Haan CA.

J Virol. 2010 Sep;84(18):9625-31. doi: 10.1128/JVI.01048-10. Epub 2010 Jul 14.


Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif.

Emerson SU, Nguyen HT, Torian U, Burke D, Engle R, Purcell RH.

J Virol. 2010 Sep;84(18):9059-69. doi: 10.1128/JVI.00593-10. Epub 2010 Jul 7.


RNA 5'-triphosphatase activity of the hepatitis E virus helicase domain.

Karpe YA, Lole KS.

J Virol. 2010 Sep;84(18):9637-41. doi: 10.1128/JVI.00492-10. Epub 2010 Jun 30.


NTPase and 5' to 3' RNA duplex-unwinding activities of the hepatitis E virus helicase domain.

Karpe YA, Lole KS.

J Virol. 2010 Apr;84(7):3595-602. doi: 10.1128/JVI.02130-09. Epub 2010 Jan 13.


Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription.

Tran K, Mahr JA, Spector DH.

J Virol. 2010 Mar;84(6):3079-93. doi: 10.1128/JVI.02236-09. Epub 2009 Dec 30.


Recent advances in Hepatitis E virus.

Meng XJ.

J Viral Hepat. 2010 Mar;17(3):153-61. doi: 10.1111/j.1365-2893.2009.01257.x. Epub 2009 Dec 21. Review.


Determination of the 5'-terminal sequence of subgenomic RNA of hepatitis E virus strains in cultured cells.

Ichiyama K, Yamada K, Tanaka T, Nagashima S, Jirintai, Takahashi M, Okamoto H.

Arch Virol. 2009;154(12):1945-51. doi: 10.1007/s00705-009-0538-y. Epub 2009 Nov 3.


Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection.

Isaacson MK, Ploegh HL.

Cell Host Microbe. 2009 Jun 18;5(6):559-70. doi: 10.1016/j.chom.2009.05.012. Review.


The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.

Moin SM, Chandra V, Arya R, Jameel S.

Cell Microbiol. 2009 Sep;11(9):1409-21. doi: 10.1111/j.1462-5822.2009.01340.x. Epub 2009 Jun 1.


ORF3 protein of hepatitis E virus is essential for virion release from infected cells.

Yamada K, Takahashi M, Hoshino Y, Takahashi H, Ichiyama K, Nagashima S, Tanaka T, Okamoto H.

J Gen Virol. 2009 Aug;90(Pt 8):1880-91. doi: 10.1099/vir.0.010561-0. Epub 2009 Apr 1.


Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes.

Satheshkumar PS, Anton LC, Sanz P, Moss B.

J Virol. 2009 Mar;83(6):2469-79. doi: 10.1128/JVI.01986-08. Epub 2009 Jan 7.

Supplemental Content

Support Center